Xortx Therapeutics Inc (XRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 716 | 890 | 964 | 661 | 875 |
| Operating Income | -716 | -890 | -964 | -661 | -875 |
| Other Income | 67 | 172 | 265 | 784 | 288 |
| Pre-tax Income | -650 | -718 | -699 | 123 | -587 |
| Net Income Continuous | -650 | -718 | -699 | 123 | -587 |
| Net Income | $-650 | $-718 | $-699 | $123 | $-587 |
| EPS Basic Total Ops | -0.13 | -0.19 | -0.19 | 0.23 | -0.20 |
| EPS Basic Continuous Ops | -0.13 | -0.19 | -0.19 | 0.24 | -0.20 |
| EPS Diluted Total Ops | -0.13 | -0.19 | -0.19 | 0.23 | -0.20 |
| EPS Diluted Continuous Ops | -0.13 | -0.19 | -0.19 | 0.24 | -0.20 |
| EPS Diluted Before Non-Recurring Items | -0.13 | -0.19 | -0.19 | 0.04 | -0.20 |
| EBITDA(a) | $-687 | $-862 | $-938 | $-635 | $-849 |